Temozolomide post pazopanib treatment failure in patients with advanced sarcoma: A case series.

about

Temozolomide post pazopanib treatment failure in patients with advanced sarcoma: A case series.

Item

http://www.wikidata.org/entity/Q46265366

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Temozolomide post pazopanib tr ...... vanced sarcoma: A case series.

@en

Temozolomide post pazopanib tr ...... vanced sarcoma: A case series.

@nl

type

Item

label

Temozolomide post pazopanib tr ...... vanced sarcoma: A case series.

@en

Temozolomide post pazopanib tr ...... vanced sarcoma: A case series.

@nl

prefLabel

Temozolomide post pazopanib tr ...... vanced sarcoma: A case series.

@en

Temozolomide post pazopanib tr ...... vanced sarcoma: A case series.

@nl

P1476

Temozolomide post pazopanib tr ...... vanced sarcoma: A case series.

@en

P2093

John L Hays

http://www.w3.org/2001/XMLSchema#string

Manojkumar Bupathi

http://www.w3.org/2001/XMLSchema#string

P2860

A phase II trial of temozolomide as a 6-week, continuous, oral schedule in patients with advanced soft tissue sarcoma: a study by the Spanish Group for Research on Sarcomas.

Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.

Phase I study of vandetanib with radiotherapy and temozolomide for newly diagnosed glioblastoma.

Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomide.

Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial.

Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected].

Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research on Sarcomas study.

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial.

Pazopanib reveals a role for tumor cell B-Raf in the prevention of HER2+ breast cancer brain metastasis.

Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas.

P304

e0188116

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0188116

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

James L Chen

P577

2017-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29141017

http://www.w3.org/2001/XMLSchema#string

P932

5687737

http://www.w3.org/2001/XMLSchema#string